Boni E Elewski Selected Research

Boni E Elewski Research Topics

Disease

28	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 11/2002
15	Onychomycosis (Tinea Unguium) 03/2024 - 03/2002
10	Infections 10/2019 - 03/2002
6	Rosacea (Acne Rosacea) 07/2015 - 11/2003
4	Psoriatic Arthritis 04/2022 - 02/2016
3	Seborrheic Dermatitis 01/2022 - 10/2007
3	Tinea Pedis (Athlete's Foot) 08/2018 - 05/2004
3	Mycoses (Diseases, Fungus) 07/2014 - 04/2007
3	Tinea Capitis 11/2011 - 11/2005
2	Pruritus (Itching) 07/2019 - 04/2016
2	Pain (Aches) 07/2019 - 04/2016
2	Dermatitis 07/2015 - 10/2002
2	Erythema 07/2015 - 11/2003
2	Dermatomycoses 11/2011 - 05/2004
1	Disease Progression 12/2023
1	COVID-19 11/2022
1	Atopic Dermatitis (Atopic Eczema) 11/2022
1	Candidiasis (Moniliasis) 03/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Ankylosing Spondylitis 01/2021
1	Hepatitis B 10/2019
1	Lichen Planus (Lichen Ruber Planus) 02/2019
1	Necrosis 03/2018
1	Acne Vulgaris 12/2016
1	Obesity 11/2015
1	Cryptococcosis 08/2015
1	Alopecia Areata 06/2013
1	Rabies (Hydrophobia) 01/2013
1	Arthritis (Polyarthritis) 01/2013
1	Alcoholism (Alcohol Abuse) 01/2013
1	Scleromyxedema (Lichen Myxedematosus) 01/2013
1	Localized Scleroderma (Morphea) 01/2013
1	Scleredema Adultorum 01/2013

Drug/Important Bio-Agent (IBA)

10	efinaconazoleIBA 03/2024 - 04/2013
9	SolutionsIBA 11/2018 - 04/2013
8	secukinumabIBA 01/2021 - 09/2013
5	Terbinafine (Lamisil)FDA LinkGeneric 03/2024 - 03/2002
4	tavaboroleIBA 03/2024 - 07/2014
4	Interleukin-17 (Interleukin 17)IBA 03/2021 - 07/2014
4	azelaic acid (Azelex)FDA Link 07/2015 - 11/2003
4	Etanercept (Enbrel)FDA Link 07/2014 - 01/2006
3	CytokinesIBA 12/2023 - 08/2015
3	Antifungal AgentsIBA 07/2015 - 04/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2013 - 01/2006
2	Ciclopirox (Loprox)FDA LinkGeneric 03/2024 - 05/2004
2	risankizumabIBA 01/2024 - 03/2021
2	ixekizumabIBA 04/2022 - 02/2016
2	guselkumabIBA 03/2021 - 10/2019
2	Ustekinumab (CNTO 1275)FDA Link 03/2021 - 10/2019
2	apremilastIBA 12/2020 - 06/2020
2	tofacitinibIBA 06/2020 - 08/2015
2	Adalimumab (Humira)FDA Link 01/2018 - 01/2013
2	potassium hydroxideIBA 07/2008 - 05/2004
2	Griseofulvin (Grifulvin V)FDA LinkGeneric 07/2008 - 11/2005
2	Alefacept (Amevive)FDA Link 03/2008 - 04/2006
2	Metronidazole (Metric)FDA LinkGeneric 01/2007 - 11/2003
1	Itraconazole (Sporanox)FDA LinkGeneric 03/2024
1	ChemokinesIBA 12/2023
1	spesolimabIBA 01/2023
1	tralokinumabIBA 11/2022
1	InflammasomesIBA 01/2022
1	PhytochemicalsIBA 08/2021
1	Interleukin-23 (Interleukin 23)IBA 03/2021
1	tildrakizumabIBA 03/2021
1	Thioguanine (Tioguanine)FDA Link 06/2020
1	Leflunomide (Arava)FDA LinkGeneric 06/2020
1	FumaratesIBA 06/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 06/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2020
1	Photosensitizing Agents (Photosensitizers)IBA 09/2019
1	Sunscreening Agents (Sunscreens)IBA 02/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2018
1	VaccinesIBA 03/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2016
1	Immunoglobulin A (IgA)IBA 03/2016
1	brodalumabIBA 02/2016
1	InterleukinsIBA 02/2016
1	BoronIBA 07/2015
1	Monoclonal AntibodiesIBA 07/2014
1	Dosage Forms (Dosage Form)IBA 07/2014
1	Econazole FDA LinkGeneric 07/2014
1	TriazolesIBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	AgarIBA 11/2011
1	Chloramphenicol (Chloromycetin)FDA Link 11/2011
1	Cycloheximide (Cicloheximide)IBA 11/2011

Therapy/Procedure

24	Therapeutics 02/2021 - 10/2002
3	Phototherapy (Light Therapy) 09/2019 - 01/2013
1	Lasers (Laser) 03/2024
1	Solid-State Lasers 03/2024
1	Gas Lasers 03/2024
1	Complementary Therapies (Alternative Medicine) 02/2021
1	Dye Lasers 09/2019
1	Electrodes (Electrode) 09/2019
1	Excimer Lasers 09/2019
1	Biological Therapy 09/2017
1	Subcutaneous Injections 01/2013
1	Injections 01/2013